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ABSTRACT
Acute erythroid leukemia (AEL) is a rare subtype of acute myeloid leukemia 
(AML), characterized by predominant erythroid proliferation. The 2008 World 
Health Organization (WHO) classification of AML defined two AEL subtypes: 
erythroleukaemia (EL), in which erythroid precursors account for 50% or more 
of all nucleated bone marrow cells and myeloblasts account for 20% or more of 
the nonerythroid cell population; and pure erythroid leukemia (PEL), in which 
erythroid precursors account for 80% or more of all nucleated bone marrow 
cells. We report the case of an elderly female patient with wasting syndrome 
and pancytopenia without evidence of blasts in peripheral blood. A diagnosis 
of PEL was established on the basis of bone marrow biopsy findings. The 
patient died on postadmission day 20, and an autopsy was performed. We 
reclassified the disease as EL on the basis of the autopsy findings, which 
included myeloblasts accounting for more than 20% of the nonerythroid cells 
in the bone marrow, as well as leukemic infiltration and myeloid metaplasia in 
solid organs, such as the liver, spleen, kidneys, adrenal glands, and abdominal 
lymph nodes. A rare disease, AEL accounts for less than 5% of all AMLs and is 
practically a diagnosis of exclusion. Autopsy reports of AEL are extremely rare 
in the literature. We demonstrate that in the case reported here, leukemia cells 
tended to infiltrate solid organs with myeloid metaplasia. Our findings also 
show that a larger neoplastic bone marrow sample is crucial to the correct 
diagnosis of EL, which is based on morphological and quantitative criteria.
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CASE REPORT
Clinical Case
An 86-year-old Black female patient sought 
medical attention with a 1-month history of generalized 
muscle weakness, dyspnea on minimal exertion, 
adynamia, apathy, loss of appetite, and depressed 
mood, all of which coincided with the death of a son. 
She had also had episodes of diarrhea accompanied 
by weight loss, having lost approximately 5 kg during 
that same period.
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The patient reported that she had been 
diagnosed with anemia of unknown etiology 6 years 
prior, having once received blood transfusion but never 
having been treated with erythropoietin. She stated 
that she had never been diagnosed with or treated for 
any type of neoplasia. She had a history of diabetes 
mellitus (DM) and hypothyroidism, as well as a more 
than 30-year history of arterial hypertension (for which 
she had been under clinical treatment), together with 
a history of coronary heart disease, having undergone 
myocardial revascularization 7 years prior. She had 
been under treatment with metformin, gliclazide, 
levothyroxine, enalapril, amlodipine, cilostazol, and 
sertraline. The patient had been smoking hand-rolled 
cigarettes for 30 years.
Physical examination at admission revealed 
normal respiration, pallor, poor general health 
status, and a body weight of 46 kg. She presented 
with a heart rate of 72 bpm, a respiratory rate of 
20 breaths/minutes, and a blood pressure of 
134/56 mmHg. In addition, she presented with no 
edema, jugular stasis, or peripheral lymph node 
enlargement. Endoscopy revealed oral candidiasis. 
Although pulmonary auscultation revealed no 
abnormalities, cardiac auscultation revealed rhythmic 
heart sounds with aortic and mitral systolic murmur. 
The abdomen was normal, and abdominal palpation 
revealed no organomegaly. Neurological examination 
revealed no abnormalities. The clinical investigation 
was based on a working diagnosis of wasting 
syndrome, with a focus on hematologic malignancy 
and solid tumors.
During her hospital stay, the patient presented 
with loss of appetite, frequent nausea, diarrhea, and 
hematochezia. Despite low food intake, there was 
no additional weight loss. Sigmoidoscopy revealed 
moderate proctitis with signs of bleeding. During 
the sigmoidoscopy, a rectal biopsy was performed. 
Histopathological examination of the biopsy specimen 
revealed mild inflammatory infiltrate composed of 
lymphomononuclear cells in the superficial layer of 
the colonic mucosa, with reactive intestinal crypts. The 
results of the laboratory tests performed are shown 
in Table 1.
A blood workup was performed and revealed 
normocytic anemia, thrombocytopenia, and 
leukoerythroblastic reaction. Urinalysis revealed 
mild proteinuria with hyaline and granular casts. 
Serology for HIV, hepatitis B, and hepatitis C was 
negative. Serum levels of vitamin B12, folic acid, 
and iron were normal, as were those of the tumor 
markers carcinoembryonic antigen, cancer antigen 
125, and cancer antigen 19-9. Upper gastrointestinal 
endoscopy revealed erosive antral gastritis. A 
computed tomography (CT) scan of the abdomen and 
pelvis revealed mild splenomegaly and atheromatous 
aorta. A CT scan of the chest revealed atheromatous 
aorta, normal lung parenchyma, and no lymph node 
enlargement. An echocardiogram showed mild left 
Table 1 – Laboratory test results
Test Measure Value Reference Test Measure Value Reference
Hemoglobin g.dL–1 9.7 12.3-15.3 Creatinine mg.dL–1 2.2 0.4-1.3
Hematocrit % 31 36.0-45.0 Urea mg.dL–1 121 10-50
MCV fl 85 80-96 Ionized calcium mmol.L–1 1.14 1.15-1.35
RDW % 16.1 11-16 Sodium mEq.L–1 132 136-146
Leukocytes mm3 9,000 4.4-11.3 × 103 Potassium mEq.L–1 4.2 3.5-5.0
Myelocytes % 2 0 AST U.L–1 20 10-31
Metamyelocytes % 1 0 ALT U.L–1 15 9-36
Band neutrophils % 22 1-5 ALP U.L–1 1445 10-100
Segmented neutrophils % 55 46-75 Total bilirubin mg.dL–1 0.3 0.3-1.2
Eosinophils % 0 1-4 Total proteins g.dL–1 5.8 6.0-8.0
Basophils % 0 0-2.5 Albumin g.dL–1 2.5 3.0-5.0
Lymphocytes % 12 18-40 DHL U.L–1 3300 120-246
Monocytes % 8 2-9 TSH µUI.L–1 2.55 0.55-4.78
Platelets mm3 80,000 150-400 × 103 Prothrombin time INR 1.23 1
MCV, mean corpuscular volume; RDW, red cell distribution width; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline 
phosphatase; TSH, thyroid stimulating factor; INR, international normalized ratio.
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ventricular hypertrophy, inferior wall hypokinesia, 
mitral insufficiency, and aortic stenosis.
There was a progressive decrease in leukocyte 
and platelet counts (which dropped to 1,100 and 
5,000 cells.mm–3, respectively), accompanied by 
a worsening of renal function. After a failed bone 
marrow (BM) aspiration (i.e., a “dry tap”), the patient 
underwent BM biopsy, which revealed extensive 
infiltration of the BM by aggregates of large, atypical 
cells (approximately 70%), the immunophenotype 
of which was consistent with that of cells of the 
erythroid lineage (positive for glycophorin A and 
partially positive for CD117); other findings included 
extensive areas of necrosis, numerous mitotic figures, 
and markedly reduced BM reserve (Figure 1). Those 
findings were consistent with a diagnosis of pure 
erythroid leukemia (PEL), in accordance with the 
World Health Organization (WHO) classification of 
acute myeloid leukemia (AML),1 or M6, in accordance 
with the French-American-British (FAB) classification.2
Despite the supportive treatment administered, 
the patient presented with progressive worsening of 
overall health status, decreased hemoglobin levels 
(having received a transfusion of packed red cells), 
dyspnea, abdominal distension, and altered level of 
consciousness. The patient died on postadmission 
day 20, and an autopsy was performed.
Autopsy Findings
The abdominal and thoracic cavities were 
opened, revealing no ectopia or effusion. There 
was mild hepatomegaly, the liver weighing 2,100 g 
(reference value, 1,400-1,600 g). On sectioning, 
the liver parenchyma had a mottled appearance, 
suggestive of passive congestion, with no evidence 
of nodular areas. The spleen showed a slight increase 
in volume (weight, 239 g; reference value, 150-250 g), 
the splenic parenchyma was homogeneous, as well 
as being wine-red on sectioning. The kidneys (right 
kidney weight, 180 g; left kidney weight, 200 g; 
reference value, 115-155 g) had a granular outer 
surface and an appearance typical of renal vascular 
disease, with multiple retention cysts of less than 
1.0 cm in diameter. In the right kidney, we found a 
solid, yellowish nodule of 1.0 cm in diameter in the 
cortical region. The heart (weight, 385 g; reference 
value, 275 ± 75 g) showed fibrous adhesions to the 
pericardium. On sectioning, revealed left ventricular 
hypertrophy, the anterior wall of the left ventricle 
Figure 1 – Photomicrographs of bone marrow biopsy findings: A- bone marrow with increased cellularity and 
infiltration by immature erythroid cells (some binucleated) with voluminous nuclei, prominent nucleoli, and 
basophilic cytoplasm (hematoxylin and eosin [H&E]; magnification, ×100); B- extensive area of coagulative 
necrosis of neoplastic cells (H&E; magnification, ×200); C- immature erythroid cells diffusely positive for 
glycophorin A (immunohistochemistry [IHC]; magnification, ×100); D- CD117-positive (IHC; magnification, 
×200); E- cells of the granulocytic series focally positive for myeloperoxidase (IHC; magnification, ×100); and 
F- CD34 positivity in blasts (in the topography of myeloperoxidase-positive cells) and in small vessels (IHC; 
magnification, ×400).
14
Autopsy and Case Reports 2011; 1(4): 11-20  Ferreira CR, Lima FR, Goto EH, et al.
showing a whitish area, which was suggestive of 
prior myocardial infarction (Figure 2).
In the right lung (right lung weight, 355 g; 
reference value, 450 g—left lung weight, 295 g; 
reference value, 375 g), we identified a small, red-
wine colored nodule measuring 0.5 cm in diameter. We 
opened the gastrointestinal tract and found hyperemia 
of the rectal mucosa. The aorta was affected by severe 
atherosclerosis. No uterus was found.
Microscopic examination of the BM from iliac 
crests and right and left ribs revealed extensive 
necrotic areas, interspersed with areas of infiltration 
by atypical undifferentiated cells with large nuclei and 
prominent nucleoli, sometimes binucleated and had 
a basophilic cytoplasm (about 80% of the nucleated 
cells). Residual hematopoietic tissue was represented 
by cells of the granulocytic lineage, with evident 
delay in maturation and very few megakaryocytes. 
Immunohistochemical analysis revealed that the 
immunophenotype of the atypical undifferentiated 
cells was similar to that of those analyzed after the BM 
biopsy, i.e., glycophorin A-positive and CD117-positive, 
as well as CD34-negative. The immunophenotype of 
the granulocytic series was myeloperoxidase (MPO)-
positive and CD117-positive, as well as positive co-
expression of CD34 (in 20-30% of the nucleated cells), 
showing the presence of myeloblasts in more than 
20% of the nonerythroid nucleated cells (Figure 3). 
The malignancy was reclassified as acute erythroid 
leukemia (AEL) of the erythroleukaemia (EL) subtype 
(also known as erythroid/myeloid), in accordance with 
the WHO classification.1
Immunohistochemistry revealed membrane 
positivity for E-cadherin in very few of the cells of 
the BM biopsy, namely in those that were large 
and immature (Figure 4). In contrast, E-cadherin 
immunohistochemistry examination of the BM 
sections obtained during the autopsy revealed no 
such evidence.
The solid organs, namely the liver, spleen, 
kidneys, adrenal glands, and abdominal lymph nodes, 
were found to be infiltrated by leukemia cells. The 
infiltration was accompanied by myeloid metaplasia, 
which was particularly evident in the spleen and 
liver. We also found severe megakaryocyte atypia, 
Figure 2 – Panoramic view of solid organs and the heart: A- liver parenchyma with a mottled appearance, 
suggestive of passive congestion; B- homogeneous, wine-red splenic parenchyma; C- right and left kidneys 
with granular surface and retention cysts; and D- heart, showing fibrous adhesions to the pericardium.
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Figure 3 – Photomicrographs of autopsy findings in bone marrow: A- bone marrow with increased cellularity 
and infiltration by immature erythroid cells (hematoxylin and eosin [H&E]; magnification, ×100); B- immature 
erythroid cells (some binucleated) with voluminous nuclei, prominent nucleoli, and basophilic cytoplasm (H&E; 
magnification, ×200); C- immature erythroid cells diffusely positive for glycophorin A (immunohistochemistry 
[IHC]; magnification, ×100); D- medium-sized immature myeloid cells within sinusoids (H&E; magnification, 
×200); E- myeloperoxidase-positive immature myeloid cells predominantly within sinusoids (IHC; magnification, 
×200); and F- positivity for CD34 in blasts (in the topography of myeloperoxidase-positive cells) and in small 
vessels (IHC; magnification, ×400).
Figure 4 – Photomicrographs of bone marrow biopsy sample: A and B- very few cells (large and immature) 
showing positivity for E-cadherin (immunohistochemistry; magnification, ×400).
including some with with multilobulated nuclei and 
coarse chromatin (Figures 5, 6, and 7).
The nodule in the right lung represented 
diffuse alveolar damage. In the renal parenchyma, 
we found retention cysts and mesangioproliferative 
glomerulonephritis secondary to DM, as well as a 
small renal clear cell carcinoma in the 1 cm right 
kidney nodule described above.
DISCUSSION
The pure erythroblast proliferation is very rare. 
AEL accounts for less than 5% of all AMLs.1 The 
diagnosis of AEL has been controversial since the 
initial concepts of the entity were first described by 
Di Guglielmo, in mid-1917. Di Guglielmo described 
two forms of the disease, namely erythremic myelosis 
(the more common form) and acute erythremia.2,3 In 
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Figure 5 – Photomicrographs of the spleen: A- red pulp of the spleen infiltrated by immature erythroid cells, 
with atypical megakaryocytes (hematoxylin and eosin [H&E]; magnification, ×100); B- immature erythroid cells, 
with atypical megakaryocytes (H&E; magnification, ×200); C- immature erythroid cells (some binucleated) 
with voluminous nuclei, prominent nucleoli, and basophilic cytoplasm (H&E; magnification, ×200); and D- red 
pulp of the spleen showing myeloid metaplasia, represented by atypical megakaryocytes and erythroid cell 
colonies (H&E; magnification, ×200).
1976, and again in a revision made in 1985, the FAB 
Cooperative Group classified AEL as M6, a subtype 
of AML characterized by erythroblasts accounting 
for 50% or more of all BM hematopoietic cells and 
myeloblasts accounting for 30% or more of all 
nonerythroid cells.4,5 Some authors have informally 
expanded the category to include subtypes M6a (EL) 
and M6b (PEL).6-8 The 2001 WHO classification of 
AML officially recognized PEL by dividing AEL into 
two subtypes: EL (erythroid precursors accounting 
for at least 50% of the entire BM cell population 
and myeloblasts accounting for at least 20% of the 
nonerythroid cell population); and PEL (immature 
erythroid cells accounting for at least 80% of all BM 
cells, with no evidence of a significant myeloblastic 
component).9 Although the 2008 WHO classification 
of AML was essentially the same as the previous 
classification, stricter criteria were established, entities 
such as AML with myelodysplasia-related changes (an 
entity that can present with erythroid predominance 
and that now comprises cases with 20% or more 
blasts and dysplasia involving at least 50% of cells 
of two or more lineages) and therapy-related AML 
having been created.1
We reported the case of an elderly female 
patient who presented with wasting syndrome and 
pancytopenia. On the basis of BM biopsy findings, we 
established an initial diagnosis of PEL. The analysis 
of a much larger BM sample during autopsy revealed 
that myeloblasts accounted for more than 20% of the 
nonerythroid cell population. This led us to establish 
a final diagnosis of EL. Although the understanding 
of AEL has increased over the years, the diagnostic 
criteria established in the AML classifications proposed 
by the FAB Cooperative Group4,5 and the WHO1,9 have 
always been based on morphological, quantitative, 
and immunophenotypic parameters, genetic markers 
having yet to be defined.6
The diagnostic criteria for AEL established 
in the latest WHO classification of AML1 are far 
stricter than were those established in previous 
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Figure 6 – Photomicrographs of the liver: A and B- liver parenchyma with leukemic infiltration in sinusoids 
and portal tracts (hematoxylin and eosin [H&E]; magnification, ×100); C- leukemic infiltration in hepatic 
sinusoids, with atypical megakaryocytes and focal myeloid metaplasia (H&E; magnification, ×200); and D- 
leukemic infiltration in portal tract, with immature erythroid cells (H&E; magnification, ×200).
classifications. According to the current WHO 
criteria, a history of myelodysplastic syndromes, 
myeloproliferative disorders, exposure to toxins such 
as benzene, cancer chemotherapy, immunotherapy, 
radiation therapy, or erythropoietin therapy rules 
out AEL.1,6 Such cases are currently diagnosed as 
AML with myelodysplasia-related changes or as 
therapy-related AML; this has significantly reduced 
the number of cases of AEL, which has practically 
become a diagnosis of exclusion.1,10 Although our 
patient presented with multiple comorbidities, she 
had no history of cancer treatment or diagnosis of 
myelodysplastic syndromes, her 6-year history of 
chronic anemia being possibly related to her chronic 
kidney disease and DM.
The etiology of AEL is unknown, and its 
risk factors have yet to be identified.6 The disease 
principally affects adults (mean age, 50 years), 
manifesting as nonspecific clinical symptoms 
(including pallor, fever, and anemia), and varying 
degrees of leukopenia and thrombocytopenia, 
hepatosplenomegaly being observed in up to one 
third of patients. The diagnosis of AEL is typically 
made within the first 3 months after a patient begins 
to report signs and symptoms.6,11 It is of note that, 
upon physical examination, our patient presented 
with no lymph node enlargement or organomegaly. 
However, mild splenomegaly was revealed by a CT 
scan of the abdomen. The autopsy revealed mild 
hepatosplenomegaly with leukemic infiltration, which 
also affected abdominal lymph nodes and other 
solid organs. This suggests that the tendency of 
neoplastic erythroblasts to involve solid organs is 
being underestimated, as has been reported by other 
authors.11 Also of note was the presence of myeloid 
metaplasia in the spleen and liver, a result of poor 
BM reserve. Myeloid metaplasia has been described 
in association with other BM diseases, especially 
myelofibrosis.12 We also found severe megakaryocyte 
atypia in the solid organs infiltrated by leukemia cells. 
Dysplastic megakaryocytes (or granulocytes) are more 
common and more significant in EL than in PEL.6
In cases of AEL, peripheral blood smears can 
show only cytopenias, with no evidence of blasts, 
which contributes to the difficulty in diagnosing the 
disease. Therefore, in order to establish a diagnosis of 
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AEL, morphological examination of the BM specimens 
obtained by BM aspiration and biopsy, as well as a full 
panel of antibodies for leukemia immunophenotyping 
and exclusion of differential diagnoses, is needed.6 
Immunophenotyping of AEL is best performed by 
flow cytometry of BM aspirates. However, in the 
case reported here, the diagnosis was established 
by immunohistochemical analysis of the BM biopsy 
specimen. This was due to a dry tap, which in turn 
was due to extensive necrosis. Immunohistochemistry 
reveals erythroblasts that are positive for glycophorin 
A and sometimes for CD117, similar to the normal 
pronormoblast population and the precursor cells of 
the granulocytic series in the BM.6 In cases of AEL, 
principally in those of the PEL subtype, the blasts are 
often negative for all erythroid-associated antibodies 
assessed by immunohistochemistry because many of 
the target antigens require some degree of erythroid 
maturation to be expressed, or a very dim expression 
may be detectable by immunohistochemistry.6
In the case reported here, immunohistochemi-
cal analysis of the BM biopsy specimen revealed 
an immature erythroid population with the following 
immunophenotype: glycophorin A-positive/CD117-
positive/CD34-negative/MPO-negative. The severe 
cytologic atypia, together with the formation of large 
cell aggregates, some of which were completely ne-
crotic, were morphologically suggestive of metastatic 
epithelial cancer or high-grade non-Hodgkin’s lym-
phoma. Those hypotheses were ruled out by nega-
tivity for epithelial and lymphoid markers, as deter-
mined by immunohistochemistry. The evaluation of 
the BM sample obtained during the autopsy, a sample 
with greater representation of the hematopoietic tis-
sue, revealed a significant quantity of blasts of the 
granulocytic lineage, the phenotype of which was 
diffusely positive for MPO/CD117 and focally positive 
for CD34 (>20% of nonerythroid nucleated cells). 
Those findings met the criteria for a diagnosis of EL. 
The immunohistochemical analysis of solid organs, 
such as the liver and spleen, revealed low or absent 
expression of glycophorin A in the immature erythroid 
Figure 7 – Photomicrographs of the kidney and abdominal lymph node: A- renal parenchymal infiltration by 
immature myeloid cells (hematoxylin and eosin [H&E]; magnification, ×200); B- immature erythroid cells in 
the lumen of capillary vessels (H&E; magnification, ×200); C- lymph node infiltrated by immature erythroid 
cells, with atypical megakaryocytes in the subcapsular sinus (H&E; magnification, ×100); and D- immature 
erythroid cells and atypical megakaryocytes in the subcapsular sinus (H&E; magnification, ×200).
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cells (CD117-positive/MPO-negative), suggestive of 
undifferentiated neoplastic erythroblasts.
Liu et al.13 recently reported that, among the 
hematopoietic lineages, E-cadherin was apparently 
specific to the immature erythroid lineage, with weak 
to strong membrane positivity in most erythroblasts in 
PEL and only small positive groups in EL, suggesting 
that the association between the markers E-cadherin 
and glycophorin A is useful in distinguishing between 
mature and immature precursors in BM biopsy 
specimens analyzed by immunohistochemistry. In the 
case reported here, the erythroid precursor population 
was not diffusely positive for E-cadherin. Few of the 
cells in the BM biopsy specimen were positive for 
E-cadherin, whereas all of the cells in the BM sample 
collected during autopsy were negative for E-cadherin. 
Maybe this finding supports the diagnosis of EL.
The differential diagnosis of AEL includes 
benign and malignant entities. As previously 
discussed, the diagnostic criteria for AEL established 
in the current WHO classification of AML1 include the 
need to rule out myelodysplastic syndromes (on the 
basis of patient history or cytogenetic abnormalities), 
erythropoietin therapy, and previous cancer treatment. 
In addition, in the presence of undifferentiated 
erythroblasts (as determined by morphological 
evaluation), the differential diagnosis should include 
lymphoma, myeloma/plasmacytoma, and other 
forms of leukemia, such as acute megakaryoblastic 
leukemia. Furthermore, cases of PEL are reported 
with partial expression of CD41 or CD61; whether 
these cases are better classified as acute mixed 
erythroid-megakaryoblastic leukemia or not is 
uncertain.6 A number of non-neoplastic diseases can 
cause erythroid predominance in the BM and therefore 
must be excluded before the diagnosis of AEL can 
be established; among the most common non-
neoplastic disorders that need to be excluded before 
the diagnosis of AEL is established is megaloblastic 
anemia due to nutritional deficiency of vitamin B12 
or folate.1,6
In the case reported here, we believe that 
the combination of severe atypia with necrosis and 
numerous mitoses (as revealed by examination of 
the BM biopsy specimen) left no doubt as to the 
diagnosis of malignancy. The confirmation of the 
erythroid lineage and the exclusion of other lineages 
by the immunohistochemical panel were essential in 
order to establish the diagnosis. Although the dry tap 
prevented us from performing cytological examination 
of the BM aspirate, there were no clinical findings to 
warrant a relocation of the case to another diagnostic 
category, AEL being the most likely diagnosis.
In some cases, peripheral blood smears show 
only nonspecific cytopenias and not circulating blasts. 
Similarly, BM aspirate smears can be inconclusive 
because of hypocellularity, which is related to 
necrosis, cell fragility, or fibrosis. Therefore, in such 
cases, pathologists should establish the definitive 
diagnosis of AEL by examining the BM biopsy 
specimen.6 We emphasize the need for include the 
markers of hematologic lineages in malignancies 
with severe atypia in which the markers of primary 
metastatic sites are negative in BM samples and in 
samples from other organs.
The prognosis of AEL is unfavorable. The 
clinical behavior of the disease is aggressive, the 
mean reported survival ranging from 1.5 months to 19 
months.10,11 The presence of cytogenetic abnormalities 
has recently been reported to correlate with clinical 
and biological characteristics, as well as with survival 
and treatment response. Patients with AEL with a 
complex karyotype have a worse prognosis.10,14
Here, we described the BM biopsy findings and 
autopsy findings in an elderly female patient with a 
diagnosis of AEL of the EL subtype. Autopsy reports of 
AEL are extremely rare in the literature in English.11,15 
The new, stricter, criteria established in the latest 
WHO classification of AML1 will certainly contribute 
to a deeper understanding of AEL and allow future 
molecular biology studies to define molecular markers 
of AEL. We emphasize that the collection of a larger 
BM sample plays an important role in the diagnosis of 
AEL, given that the disease can display an aggressive 
behavior, with infiltration of multiple organs, as observed 
in the case reported here.
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